CollaGenix Sues Over ANDAs For Periostat Generics

Law360, New York (October 2, 2004, 12:00 AM EDT) -- CollaGenex Pharmaceuticals Inc. has sued rival drug makers Ivax Pharmaceuticals Inc. and CorePharma LLC in a federal court over their abbreviated new drug applications (ANDAs) for a patent covering its gum disease treatment, Periostat.

CollaGenex said the complaint, filed with the U.S. District Court for the Southern District of New York, seeks an injunction against the companies from launching generic versions of Periostat.

Generics drug applicants must include with their ANDAs a statement addressing the generic drug's relationship to each Orange Book-listed patent of the original...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.